Browsing by Author Baran, Yusuf

Showing results 148 to 167 of 173 < previous   next >
Issue DateTitleAuthor(s)
2007A study of multiple drug resistance mechanisms improved against Bortezomib on multiple myeloma cell lines in vitroUyuklu, Tolga; Ural, A. Uğur; Sarper, Metal; Avcu, Ferit; Baran, Yusuf ; Elçi, Pınar; Akar, Nejat
2014Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosisTezcanlı Kaymaz, Burçin; Selvi, Nur; Adan Gökbulut, Aysun ; Aktan, Çağdaş; Gündüz, Cumhur; Saydam, Güray; Baran, Yusuf ; Kosova, Buket
Oct-2010Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cellsKosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur; Dalmızrak, Ayşegül; Yandım, Melis Kartal; Gündüz, Ufuk; Baran, Yusuf 
2015Synergistic apoptotic effects of bortezomib and methylstat inhibitor on different multiple myeloma cell linesKacı, Fatma Necmiye
2015Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell linesKacı, Necmiye; Kiraz, Yağmur ; Baran, Yusuf 
2020Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cellsKaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf 
Jan-2017Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivativesApohan, Elif; Yılmaz, Ülkü; Yılmaz, Özgür; Serindağ, Ayfer; Küçükbay, Hasan; Yeşilada, Özfer; Baran, Yusuf 
Jan-2016T cells in tumor microenvironmentKiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten 
2009Targeting ceramide metabolism increased sensitivity of Philadelphia positif chronic megacaryoblastic leukemia cells to dasatinibGençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf 
Mar-2015Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell lineTüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf 
Oct-2011Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulationBaran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim
2014Targeting sphingosine kinase-1/spingosine-1-phosphate receptor 2 signalling pathway to overcome T315I mutation in 32DCL3 cellsAdan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf 
Oct-2010Therapeutic applications of bioactive sphingolipids in hematological malignanciesEkiz, Hüseyin Atakan ; Baran, Yusuf 
May-2014Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cellsSolmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf 
2015Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cellsAdan Gökbulut, Aysun ; Baran, Yusuf 
2014Therapeutic potential of fisetin, vitexin and hesperetin on chronic myeloid leukemia cellsAdan Gökbulut, Aysun ; Baran, Yusuf 
2023Therapeutic potential of luteolin on cancerÇetinkaya, Melisa; Baran, Yusuf 
Jan-2013Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancerKartal Yandım, Melis; Apohan, Elif; Baran, Yusuf 
2010Therapeutic potential of targeting sphingolipid signaling pathways in various types of cancersBaran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde
2015Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cellsAdan Gökbulut, Aysun